Effect of histology on stereotactic body radiotherapy for non-small cell lung cancer oligometastatic pulmonary lesions

Keyphrases

• Histology 100%
• Squamous Cell Carcinoma (SqCC) 100%
• Non-small Cell Lung Cancer (NSCLC) 100%
• Stereotactic Body Radiotherapy 100%
• Pulmonary Lesions 100%
• Oligometastatic 100%
• Adenocarcinoma 83%
• Local Control 50%
• Competing Risks 50%
• Local Recurrence-free Survival 50%
• Local Failure 33%
• Risk Factors 16%
• Retrospective Cohort Study 16%
• Statistical Significance 16%
• Lung Squamous Cell Carcinoma 16%
• Lung Adenocarcinoma 16%
• Median Overall Survival 16%
• Tumor Histology 16%
• Sufficient Follow-up 16%
• Treatment Outcome 16%
• Targeted Treatment 16%
• Kaplan-Meier Analysis 16%
• Failure Risk 16%
• Local Recurrence 16%
• Recurrent Non-small Cell Lung Cancer 16%
• Cumulative Incidence Function 16%
• Metastatic Lung Disease 16%

Medicine and Dentistry

• Squamous Cell Carcinoma 100%
• Non Small Cell Lung Cancer 100%
• Stereotactic Body Radiation Therapy 100%
• Lung Lesion 100%
• Adenocarcinoma 83%
• Progression Free Survival 50%
• Overall Survival 16%
• Targeted Therapy 16%
• Lung Adenocarcinoma 16%
• Squamous Cell Lung Carcinoma 16%
• Retrospective Cohort Study 16%
• Kaplan Meier Method 16%
• Tumor Histology 16%
• Recurrent Disease 16%
• Silo-Filler's Disease 16%
• Cumulative Incidence 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Small Cell Lung Cancer 100%
• Squamous Cell Carcinoma 100%
• Lung Lesion 100%
• Adenocarcinoma 83%
• Progression Free Survival 50%
• Cohort Study 16%
• Neoplasm 16%
• Overall Survival 16%
• Recurrent Disease 16%
• Lung Disease 16%
• Lung Adenocarcinoma 16%
• Squamous Cell Lung Carcinoma 16%